Avant Diagnostics, Inc Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Settlements
Avant Diagnostics, Inc reported Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Settlements of -$1.60 million for the 12-month period ending 2018-09-30, per its 10-K filed 2019-03-01.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Purchases, Sales, Issues, Settlements
us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements · last filed 2019-03-01
- Avant Diagnostics, Inc fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, settlements for the quarter ending 2018-09-30 was -$11.20K.
- Avant Diagnostics, Inc fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, settlements for fiscal 2018 was -$1.60M.
| Period end | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Settlements 3 month | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Settlements 9 month | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Settlements 12 month |
|---|---|---|---|
| 2018-09-30 | -$11.20K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$1.60M 10-K · filed 2019-03-01 | |
| 2018-06-30 | -$1.59M 10-Q · filed 2019-01-30 |